COVID-19 in Patients With Chronic Liver Diseases

Not Recruiting

Trial ID: NCT04439084

Purpose

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Official Title

COVID-19 in Patients With Chronic Liver Diseases

Stanford Investigator(s)

Renumathy Dhanasekaran
Renumathy Dhanasekaran

Assistant Professor of Medicine (Gastroenterology)

Eligibility

Inclusion Criteria:

* Confirmed diagnosis of COVID-19
* Personal history of either

* Chronic hepatitis C
* Chronic hepatitis B
* Alcoholic liver disease
* Non alcoholic liver disease
* Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis
* Cryptogenic cirrhosis
* Hepatocellular carcinoma

Exclusion Criteria:

* Non-COVID-19 patient

Intervention(s):

other: Prospective Chart Review

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305